These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 7714223

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder.
    Lecrubier Y, Puech AJ, Azcona A, Bailey PE, Lataste X.
    Psychopharmacology (Berl); 1993; 112(1):129-33. PubMed ID: 7871001
    [Abstract] [Full Text] [Related]

  • 3. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.
    Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N.
    Acta Psychiatr Scand; 1991 Apr; 83(4):244-8. PubMed ID: 1903019
    [Abstract] [Full Text] [Related]

  • 4. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
    Adams JB, Pyke RE, Costa J, Cutler NR, Schweizer E, Wilcox CS, Wisselink PG, Greiner M, Pierce MW, Pande AC.
    J Clin Psychopharmacol; 1995 Dec; 15(6):428-34. PubMed ID: 8748432
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety.
    Smith WT, Londborg PD, Blomgren SL, Tollefson GD, Sayler ME.
    J Clin Psychopharmacol; 1999 Apr; 19(2):125-31. PubMed ID: 10211913
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
    Rickels K, Mathew S, Banov MD, Zimbroff DL, Oshana S, Parsons EC, Donahue SR, Kauffman M, Iyer GR, Reinhard JF.
    J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disorders.
    Ansseau M, Doumont A, Thiry D, Gelders Y.
    Acta Psychiatr Belg; 1983 Apr; 83(5):517-24. PubMed ID: 6670580
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR, DuPont RL, Hedges D, Haskins JT.
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [Abstract] [Full Text] [Related]

  • 16. Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.
    Bressa GM, Marini S, Gregori S.
    Int J Clin Pharmacol Res; 1987 Aug; 7(2):111-9. PubMed ID: 3108171
    [Abstract] [Full Text] [Related]

  • 17. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G, Schüle C, Lorkowski G, Baghai T, Kuhn K, Ehrentraut S.
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [Abstract] [Full Text] [Related]

  • 18. Beta 2-adrenoceptor antagonism in anxiety.
    Cooper SJ, Kelly CB, McGilloway S, Gilliland A.
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):75-7. PubMed ID: 1983780
    [Abstract] [Full Text] [Related]

  • 19. Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trial.
    Herold A, Dietrich J, Aitchison R.
    Clin Ther; 2012 Feb; 34(2):329-40. PubMed ID: 22244049
    [Abstract] [Full Text] [Related]

  • 20. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.
    Neuropsychobiology; 1997 Feb; 36(3):130-52. PubMed ID: 9313245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.